Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» HIV
HIV
New Data Shows Promise Involving Lenacapavir for the Treatment of HIV
BioSpace
Thu, 07/2/20 - 11:30 pm
Gilead Sciences
lenacapavir
HIV
Experimental HIV drug seems effective at a twice-a-year dose, study finds
Stat
Wed, 07/1/20 - 11:25 am
HIV
Gilead Sciences
lenacapavir
clinical trials
Large UK study finds no benefit to HIV antiviral in COVID-19
BioPharma Dive
Tue, 06/30/20 - 11:31 pm
HIV
antivirals
COVID-19
pandemic
Kaletra
AbbVie
Merck’s Experimental Pneumonia Vaccine Hits the Mark in Two Phase III Studies
BioSpace
Mon, 06/22/20 - 08:38 pm
Merck
vaccines
V114
clinical trials
HIV
pneumonia
pneumococcal disease
Could Gilead Sciences Have an HIV Cure Waiting in the Wings?
Motley Fool
Sun, 06/14/20 - 10:49 pm
Gilead Sciences
HIV
bNab
Life-Saving HIV Drug PrEP On NHS Delayed Amid Coronavirus Pandemic
Forbes
Fri, 06/5/20 - 10:38 am
HIV
NHS
PrEP
pandemic
COVID-19
ImmunityBio’s Promising Preclinical HIV Drug is Moving into Phase I Trials
BioSpace
Thu, 05/21/20 - 11:11 pm
ImmunityBio
HIV
clinical trials
N-803
GSK sub’s injectable outperforms Gilead in late-stage PrEP trial
Endpoints
Tue, 05/19/20 - 10:33 am
GSK
Gilead Sciences
HIV
PrEP
Truvada
ViiV Healthcare
cabotegravir
More threat to Gilead's HIV business? GlaxoSmithKline touts long-acting injectable PrEP win against Truvada
Fierce Pharma
Mon, 05/18/20 - 11:12 am
GSK
Gilead Sciences
Truvada
cabotegravir
HIV
PrEP
Gilead charges CDC with contract breach on HIV research
Seeking Alpha
Sun, 04/26/20 - 08:31 pm
Gilead Sciences
CDC
patents
lawsuits
HIV
R&D
HIV And Flu Drugs Prove Futile In Fight Against Coronavirus
Forbes
Tue, 04/21/20 - 11:51 pm
China
clinical trials
HIV
Kaletra
Arbidol
COVID-19
J&J HIV drug already in Covid-19 clinical trials flunks in vitro study
MedCity News
Wed, 04/8/20 - 11:42 pm
JNJ
COVID-19
clinical trials
Prezista
HIV
ACC: Amgen's Repatha cuts cholesterol in rarely studied HIV patients
Fierce Pharma
Sat, 03/28/20 - 11:30 pm
ACC
Repatha
HIV
clinical trials
Amgen
AbbVie gives up patent rights to HIV med Kaletra amid COVID-19 tests: report
Fierce Pharma
Mon, 03/23/20 - 11:37 pm
AbbVie
HIV
Kaletra
patents
COVID-19
J&J warns doctors not to count on Prezista as a COVID-19 treatment
Fierce Pharma
Tue, 03/17/20 - 12:06 pm
COVID-19
coronaviruses
Prezista
HIV
JNJ
ViiV, UNC-Chapel Hill renew HIV partnership for another five years
Pharma Times
Wed, 03/11/20 - 07:29 pm
HIV
ViiV
UNC-Chapel Hill
AbbVie to Test HIV Drug as a Potential Coronavirus Treatment
Motley Fool
Tue, 03/10/20 - 11:03 am
AbbVie
Kaletra
COVID-19
coronaviruses
HIV
Gilead's Descovy not worth the higher price over forthcoming Truvada generics: study
Fierce Pharma
Tue, 03/10/20 - 10:50 am
Gilead Sciences
Descovy
Truvada
HIV
drug pricing
GSK's ViiV touts 2-month HIV data as sister injection Cabenuva awaits FDA redemption
Fierce Pharma
Mon, 03/9/20 - 10:39 am
HIV
FDA
GSK
Cabenuva
ViiV
Where Will Gilead Sciences Be in 10 Years?
Motley Fool
Sat, 02/22/20 - 11:23 pm
Gilead Sciences
HIV
hepatitis C
Pages
« first
‹ previous
…
3
4
5
6
7
8
9
10
11
…
next ›
last »